• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Reata Pharmaceuticals

edit

Reata Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs for cancer, inflammation, and neurodegenerative diseases. It offers antioxidant inflammation modulating drugs, as well as drugs that correct protein misfolding. The company also develops drugs for the treatment of renal/cardiovascular and autoimmune diseases. The company was formerly known as Reata Discovery, Inc. and changed its name to Reata Pharmaceuticals, Inc. in May 2005. The company was founded in 2002 and is based in Irving, Texas.

Recent Milestones

edit

• 
  Reata Pharmaceuticals received $78M in Venture Round funding. (7/12/10)
  Posted 7/12/10 at 5:48pm via reatapharma.com
• 
  Reata Pharmaceuticals added Warren Huff as President and CEO.
  Posted 7/12/10 at 5:48pm

Videos

Screenshots

edit

Sources

1. Reata Pharmaceuticals Completes $78 Million Equity Financing for Second Pivotal Trial of Bardoxolone Methy (reatapharma.com) [edit]